News

Roswell Park Expands EDDY Program with Region’s First Mobile Screening Center for Breast and Prostate Cancer

Determined to make cancer screening accessible for people across Western New York, Roswell Park Comprehensive Cancer Center is proud to unveil the region’s most comprehensive mobile cancer screening initiative.

News

Roswell Park at ASH 2025

Roswell Park invites you to come meet some of our nationally recognized experts in transplant and cellular therapy and hematologic malignancies at this year’s ASH conference in Orlando, taking place December 6-9, 2025. 

Video

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.

News

Biomarker-Driven “Umbrella” Study Matches AML, MDS Patients with Specific Clinical Trials

Using bone marrow and blood to identify specific biomarkers, a new “umbrella” screening study matches patients diagnosed with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) to one of five clinical trials evaluating precision-medicine ...

News

Roswell Park Experts Share Latest Hematology Research at 67th ASH Annual Meeting

Experts from Roswell Park Comprehensive Cancer Center will discuss their latest discoveries at the 67th annual meeting of the American Society of Hematology (ASH) December 6-9 in Orlando, Florida.

News

Roswell Park Experts Host Symposium to Reconnect the “Meaning in Medicine”

Join leaders from Roswell Park Comprehensive Cancer Center, along with speakers from Levine Cancer Institute and the Jacobs School of Medicine at the State University of New York at Buffalo for a special day-long symposium, “Finding the ...